Home LiteratureArticle Details
PMID: 11533199 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.

Journal of virology ·Vol. 75 ·No. 19 ·2001-10-00 ·Pages 9357-66

Tang S, Murakami T, Agresta BE, Campbell S, Freed EO, Levin JG

Abstract

A group of conserved hydrophobic residues faces the interior of the coiled-coil-like structure within the N-terminal domain of the human immunodeficiency virus type 1 (HIV-1) capsid protein (CA). It has been suggested that these residues are important for maintaining stable structure and functional activity. To investigate this possibility, we constructed two HIV-1 clones, in which Trp23 or Phe40 was changed to Ala. We also constructed a third mutant, D51A, which has a mutation that destroys a salt bridge between Pro1 and Asp51. All three mutants are replication defective but produce virus particles. Mutant virions contain all of the viral proteins, although the amount and stability of CA are decreased and levels of virion-associated integrase are reduced. The mutations do not affect endogenous reverse transcriptase activity; however, the mutants are blocked in their ability to initiate reverse transcription in infected cells and no minus-strand strong-stop DNA is detected. The defect in reverse transcription is associated with striking defects in the morphology of mutant virus cores, as determined by transmission electron microscopy. Our data indicate that the mutations made in this study disrupt CA structure and prevent proper maturation of virus cores. We propose that this results in a defect in core stability or in an early postentry event preceding reverse transcription.

MeSH Terms
Gene Products, gag/genetics HIV Infections/virology HIV-1/physiology HeLa Cells Humans Mutation Transcription, Genetic/genetics Virus Replication/genetics
Chemicals
Gene Products, gag
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Tang S
Laboratory of Molecular Genetics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.
Murakami T
Agresta B E
Campbell S
Freed E O
Levin J G
References (57)
57 references, click to expand
  1. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1.
    J Virol. 2000 Feb;74(3):1168-77 PMID: 10627527
  2. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Virology. 2000 Mar 15;268(2):294-307 PMID: 10704338
  3. Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag).
    J Virol. 2000 Jul;74(13):6198-202 PMID: 10846106
  4. Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants.
    J Virol. 2001 Jan;75(1):242-50 PMID: 11119594
  5. Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions.
    J Virol. 2001 Aug;75(15):6850-6 PMID: 11435564
  6. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D.
    J Virol. 1974 Jul;14(1):152-61 PMID: 4134468
  7. In vitro synthesis of infectious DNA of murine leukaemia virus.
    Nature. 1977 Sep 8;269(5624):122-6 PMID: 71657
  8. Functional analysis of reverse transcription by a frameshift pol mutant of murine leukemia virus.
    Virology. 1985 Oct 15;146(1):146-52 PMID: 2412343
  9. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  10. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers.
    Cancer Res. 1987 Nov 1;47(21):5616-9 PMID: 3664468
  11. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.
    J Virol. 1988 Nov;62(11):3993-4002 PMID: 3262776
  12. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range.
    J Virol. 1991 Jan;65(1):162-9 PMID: 1845882
  13. Assembly and morphology of HIV: potential effect of structure on viral function.
    AIDS. 1991 Jun;5(6):617-37 PMID: 1652977
  14. Form, function, and use of retroviral gag proteins.
    AIDS. 1991 Jun;5(6):639-54 PMID: 1883539
  15. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.
    Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):70-4 PMID: 1729720
  16. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle.
    J Virol. 1992 Mar;66(3):1717-25 PMID: 1371173
  17. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences.
    J Virol. 1992 Apr;66(4):1856-65 PMID: 1548743
  18. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.
    J Virol. 1992 Apr;66(4):2232-9 PMID: 1548759
  19. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses.
    J Virol. 1992 Aug;66(8):4893-900 PMID: 1378513
  20. Viral DNA carried by human immunodeficiency virus type 1 virions.
    J Virol. 1992 Aug;66(8):5067-74 PMID: 1378514
  21. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants.
    J Virol. 1993 Jul;67(7):4264-73 PMID: 7685414
  22. Maturation of dimeric viral RNA of Moloney murine leukemia virus.
    J Virol. 1993 Sep;67(9):5443-9 PMID: 8350405
  23. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.
    J Virol. 1994 Apr;68(4):2503-12 PMID: 8139032
  24. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.
    J Virol. 1994 Aug;68(8):5013-8 PMID: 8035501
  25. Functional domains of the capsid protein of human immunodeficiency virus type 1.
    J Virol. 1994 Dec;68(12):8180-7 PMID: 7966609
  26. Specific incorporation of cyclophilin A into HIV-1 virions.
    Nature. 1994 Nov 24;372(6504):359-62 PMID: 7969494
  27. Functional association of cyclophilin A with HIV-1 virions.
    Nature. 1994 Nov 24;372(6504):363-5 PMID: 7969495
  28. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.
    J Virol. 1995 Feb;69(2):642-50 PMID: 7815527
  29. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.
    J Virol. 1995 Mar;69(3):1984-9 PMID: 7853546
  30. Nascent human immunodeficiency virus type 1 reverse transcription occurs within an enveloped particle.
    J Virol. 1995 Jun;69(6):3675-82 PMID: 7745716
  31. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.
    J Virol. 1995 Jun;69(6):3949-54 PMID: 7745752
  32. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
    J Virol. 1995 Nov;69(11):6810-8 PMID: 7474093
  33. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.
    J Virol. 1996 Jun;70(6):3551-60 PMID: 8648689
  34. Structure of the amino-terminal core domain of the HIV-1 capsid protein.
    Science. 1996 Jul 12;273(5272):231-5 PMID: 8662505
  35. HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro.
    Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7577-81 PMID: 8755517
  36. Crystal structure of dimeric HIV-1 capsid protein.
    Nat Struct Biol. 1996 Sep;3(9):763-70 PMID: 8784350
  37. Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection.
    Virology. 1996 Aug 15;222(2):339-51 PMID: 8806518
  38. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle.
    J Virol. 1996 Dec;70(12):8645-52 PMID: 8970990
  39. Role of Vif in human immunodeficiency virus type 1 reverse transcription.
    J Virol. 1996 Dec;70(12):8701-9 PMID: 8970997
  40. A conformational switch controlling HIV-1 morphogenesis.
    EMBO J. 2000 Jan 4;19(1):103-13 PMID: 10619849
  41. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid.
    Cell. 1996 Dec 27;87(7):1285-94 PMID: 8980234
  42. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA.
    J Virol. 1997 Jul;71(7):5178-88 PMID: 9188585
  43. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein.
    Science. 1997 Oct 31;278(5339):849-53 PMID: 9346481
  44. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.
    EMBO J. 1998 Mar 16;17(6):1555-68 PMID: 9501077
  45. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
    J Virol. 1998 May;72(5):4116-26 PMID: 9557701
  46. N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles.
    J Virol. 1998 Jun;72(6):4798-810 PMID: 9573245
  47. Generation of HIV-1/HIV-2 cross-reactive peptide antisera by small sequence changes in HIV-1 reverse transcriptase and integrase immunizing peptides.
    J Biomed Sci. 1998;5(3):192-202 PMID: 9678490
  48. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication.
    Trends Biochem Sci. 1998 Aug;23(8):297-301 PMID: 9757830
  49. HIV-1 gag proteins: diverse functions in the virus life cycle.
    Virology. 1998 Nov 10;251(1):1-15 PMID: 9813197
  50. Structural biology of HIV.
    J Mol Biol. 1999 Jan 8;285(1):1-32 PMID: 9878383
  51. Assembly and analysis of conical models for the HIV-1 core.
    Science. 1999 Jan 1;283(5398):80-3 PMID: 9872746
  52. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex.
    J Virol. 1999 Mar;73(3):2126-35 PMID: 9971795
  53. Alterations to both the primary and predicted secondary structure of stem-loop IIIc of the hepatitis C virus 1b 5' untranslated region (5'UTR) lead to mutants severely defective in translation which cannot be complemented in trans by the wild-type 5'UTR sequence.
    J Virol. 1999 Mar;73(3):2359-64 PMID: 9971819
  54. Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid.
    Virology. 1999 Apr 25;257(1):261-74 PMID: 10208939
  55. Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.
    J Virol. 1999 Jun;73(6):4728-37 PMID: 10233933
  56. Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy.
    J Virol. 1999 Aug;73(8):7050-5 PMID: 10400808
  57. Association of Nef with the human immunodeficiency virus type 1 core.
    J Virol. 1999 Oct;73(10):8824-30 PMID: 10482638
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2001-10-00
Pages
9357-66
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC114504
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]